Vidwan-ID : 416254



  • Dr Venkatesan Jayaprakash

  • Professor
  • Birla Institute of Technology, Mesra
Publications 2005 - 2023

Publications

  • 85
    Journal Articles
  • 4
    Book Chapter
  • 9
    Review
  • 5
    Short Survey
  • 6
    Projects
  • 2
  • 1
  • 15

Citations / H-Index

2089 Citations
29 h-index
521 Citations

Altmetrics

21
22
29
190
127

Google Scholar

Co-author Network


Expertise

Pharmacology and Pharmacy

Molecular Modeling and Drug Design and Synthesis of Small Molecule Heterocycles Against Targets of Therapeutical Importance

Personal Information

Dr Venkatesan Jayaprakash

Male
Department of Pharmaceutical Sciences and Technology Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra
Ranchi, Jharkhand, India - 835215


Experience

  • Professor

    Department of Pharmaceutical Sciences and Technology

    Birla Institute of Technology, Mesra

  • Associate Professor

    Department of Pharmaceutical Sciences and Technology

    Birla Institute of Technology, Mesra

  • Assistant Professor

    Department of Pharmaceutical Sciences and Technology

    Birla Institute of Technology, Mesra

  • Lecturer

    Department of Pharmaceutical Sciences and Technology

    Birla Institute of Technology, Mesra


Qualification

  • Ph.D.

    Birla Institute of Technology, Mesra

  • PGDCAQM

    University of Hyderabad, Hyderabad

  • M. Pharmacy

    Banaras Hindu University, Varanasi

  • B. Pharmacy

    Madras Medical College, Madras

  • D. Pharmacy

    Coimbatore Medical College, Coimbatore


Honours and Awards

2021

WHO's WHO

Marquis

2011

WHO's WHO

Marquis

1996

Junior Research Fellow

UGC, Govt. of India

2021

WHO's WHO

Marquis

2011

WHO's WHO

Marquis

1996

Junior Research Fellow

UGC, Govt. of India

Read Less

Doctoral Theses Guided

2023

Design and development of antiviral agents for the treatment of Dengue viral infection 

Sheikh Murtaza, Birla Institute of Technology, Mesra

2022

Mycobactin synthesis inhibitors as antitubercular agents

Mousumi Shyam, Birla Institute of Technology, Mesra

2019

Design synthesis and biological evaluation of Cytochrome P450 inhibitors as anticancer agents

Mohd Usman Mohd Siddique, Birla Institute of Technology, Mesra

Read More
2023

Design and development of antiviral agents for the treatment of Dengue viral infection 

Sheikh Murtaza, Birla Institute of Technology, Mesra

2022

Mycobactin synthesis inhibitors as antitubercular agents

Mousumi Shyam, Birla Institute of Technology, Mesra

2019

Design synthesis and biological evaluation of Cytochrome P450 inhibitors as anticancer agents

Mohd Usman Mohd Siddique, Birla Institute of Technology, Mesra

2019

Design and synthesis of PPAR modulators as possible antidiabetic agents

Sabina Yasmin, Birla Institute of Technology, Mesra

2018

Design synthesis and biological screening of monoamine oxidase inhibitors

Vishnu Nayak, Birla Institute of Technology, Mesra

2018

Design synthesis and screening of small molecule inhibitors against Dengue virus

Timiri Ajay Kumar, Birla Institute of Technology, Mesra

2017

Design and synthesis of antiviral agents for Chikungunya viral infection

Surender Singh Jadav, Birla Institute of Technology, Mesra

Read Less

Membership In Professional Bodies

1999

Association of Pharmacy Teachers of India

Life Member

1999

Association of Pharmacy Teachers of India

Life Member

Read Less

Membership In Committees

2024

QIP Centre, Birla Institute of Technology, Mesra

QIP Coordinator

2024

Institution Innovation Council, Birla Institute of Technology, Mesra

Member

2024

Intellectual Property Rights Cell (IPRC)

Convenor

Read More
2024

QIP Centre, Birla Institute of Technology, Mesra

QIP Coordinator

2024

Institution Innovation Council, Birla Institute of Technology, Mesra

Member

2024

Intellectual Property Rights Cell (IPRC)

Convenor

2023

Committee for KAPILA

Convenor

2023

Institutional Biosafety Committee (IBSC), BIT Mesra

Member Secretary

2020

Institute Feedback Committee, BIT Mesra

Member

2019

Internal Complaint Committee (ICC), BIT Mesra

Member,

2019

Committee for policy formulation on Academic programs, BIT Mesra

Member

2017

Internal Quality Assurance Cell (IQAC), BIT Mesra

Member

Read Less

Research Projects

Aptamer-based diagnostic kit for detection of Corona virus infection (CoVapt)

Funding Agency : SERB

Design & development of inhibitors of DENV methyl transferase for the treatment of Dengue viral infection

Funding Agency : AICTE

Design and synthesis of substrate based peptide inhibitors of DENV protease for the treatment of Dengue viral infections

Funding Agency : SERB

Read More

Aptamer-based diagnostic kit for detection of Corona virus infection (CoVapt)

Funding Agency : SERB

Design & development of inhibitors of DENV methyl transferase for the treatment of Dengue viral infection

Funding Agency : AICTE

Design and synthesis of substrate based peptide inhibitors of DENV protease for the treatment of Dengue viral infections

Funding Agency : SERB

Phenyloxazoline synthetase inhibitiors as antitubercular agents (POSIAA)

Funding Agency : SERB

Grid-based virtual screening for TB (Grid-ViSiT)

Funding Agency : AICTE

Expanding the scope of anti-cancer drug discovery: A multi-targeted approach for simultaneous inhibition of CDK4, CYP1B1, and tubulin proteins

Funding Agency : ICMR

Read Less

Patents




Read More






Read Less